comparemela.com
Home
Live Updates
Jeffrey Matous - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Jeffrey matous - Page 1 : comparemela.com
Dr Matous on the Use Talquetamab/Pomalidomide in Relapsed/Refractory Multiple Myeloma
Jeffrey Matous, MD, discusses outcomes from the phase 1b MonumenTAL-2 trial with the combination of talquetamab and pomalidomide in patients with relapsed/refractory multiple myeloma.
United states
Talquetamab pomalidomide
Jeffrey matous
University of colorado
Colorado blood cancer institute
Refractory multiple
Ash annual meeting and exposition
Onclive tv
Multiple myeloma
Barriers to Appropriate RRMM Care
Barriers to sufficient multiple myeloma treatment are explored.
United states
University of minnesota
Jeffrey matous
Kirollos hanna
Zahra mahmoudjafari
Beth faiman
Minnesota oncology
Epic systems
Mayo clinic
Financial Considerations in RRMM Treatment Landscape
In their closing thoughts, the panelists discuss financial considerations for treating patients with RRMM.
United states
Beth faiman
Zahra mahmoudjafari
Jeffrey matous
Kirollos hanna
Jeff wolf
Cost of care
Sequencing data
Reimbursement model
Establishing Adequate Patient Support Systems
Building strong support systems from both clinical and personal perspectives can drive optimal patient outcomes.
Beth faiman
Tom martin
Suzanne trudel
Kirollos hanna
Zahra mahmoudjafari
Jeffrey matous
Support system
RRMM Treatment Regimen Considerations
Panelists discuss relapsed/refractory multiple myeloma treatment regimen strategies.
United states
Beth faiman
Jeffrey matous
Zahra mahmoudjafari
Multiple myeloma
B cell aplasia
Growth factor
vimarsana © 2020. All Rights Reserved.